Search over 3,000 reports

    Optruma - API Insights, 2017

    Optruma - API Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 30
    Geography: Global
    Delivery Timeline: 48 Hours
    SKU: DIDA0122
    DelveInsight's, Optruma - API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Optruma. The report also highlights the patent details of Optruma.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
    Scope:
    Evaluate the marketing status of Optruma to exploit opportunities for generic Optruma development opportunities
    Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Optruma
    API intelligence over Optruma and gaining primary intelligence over Active Ingredient manufacturers by country
    Make more informed business decisions from insightful and in-depth analysis of the Optruma's performance
    Optruma Overview
    Optruma Global Sales Assessment
    Optruma Historical Global Sales
    Optruma Forecasted Global Sales
    Product Description
    Mechanism of Action
    Pharmacodynamic Properties
    Pharmacokinetic Properties
    Product Details by country
    Patent Information
    Global API Manufacturers Assessment
    Active Pharmaceutical Ingredient (API) Manufacturers by Country
    Active Pharmaceutical Ingredient (API) Manufacturers by Region
    Appendix
    Methodology
    Consulting Services
    Disclaimer
    About DelveInsight
    Table 1: Optruma Historical Global Sales from 2009-2016 (in million USD)
    Table 2: Optruma Forecasted Global Sales from 2017-2022 (in million USD)
    Table 3: Optruma General Description
    Table 4: Product Details by country
    Table 5: Patent Information
    Table6: API Manufacturers by country
    Table 7: API Manufacturers by Region
    Figure 1: Optruma Historical Global Sales from 2009-2016 (in million USD)
    Figure 2: Optruma Forecasted Global Sales from 2017-2022 (in million USD)
    Figure 3: Optruma Patent Details
    Figure 4: Optruma API Manufacturers by Country
    Figure 5: Optruma API Manufacturers by Region
    Optruma
    Eli Lilly
    osteoporosis
    Optruma Marketed Drugs Overview
    Optruma Market Assessment
    Optruma API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Optruma US DMF
    Optruma US Drug Master Files
    Optruma Active Substance Master File/ EUDMF
    Optruma Generic players
    Optruma Patent Expiration
    Optruma Patent Exclusivity
    Optruma API Manufacturers
    Optruma Global Forecasted Sales Figure
    • Single User License
      (20% Off)
      $500.00
      $400
    • Site License
      (30% Off)
      $1,000.00
      $700
    • Global License
      (40% Off)
      $1,500.00
      $900

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap